Skip to content
WeighLab
Menu
Ranked #321 · Grade C

Aurelius Health Group review

Aurelius Health Group is a telehealth platform built around compounded tirzepatide microdosing — a low-dose dual GIP/GLP-1 protocol rather than standard full-dose therapy — with optional NAD+, L-carnitine.

Visit Aurelius Health Group Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
Not disclosed
Tirzepatide
$199/mo (microdose tier, compounded)
Coverage
Coverage not published
Brand-name
Compounded only

Tirzepatide · modeled / year

$2,388

Pricing verified August 2026

The Index scorecard

Aurelius Health Group scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month51/100
Price Transparency78/100
Nationwide Access24/100
Formulation Options53/100
Clinical Oversight76/100
Contract Flexibility61/100

Where the value is

  • Pricing fully published and bundled: $89 first month, then $199/mo all-in — more transparent than most compounded brands
  • LegitScript Certified
  • Care-inclusive model: consults, monthly monitoring, and secure messaging rather than Rx-only
  • Unusually candid about the limited evidence base for microdosing

The tradeoffs

  • The advertised $89 is a first-month new-patient rate; every month after it is $199
  • This is a 1 mg microdose program and nothing else — no labeled therapeutic dose is sold, so it is not an alternative to a full-dose prescription
  • No state count is published, only 'most US states', confirmed at intake
  • The site's own comparison table calls 2.4 mg/week the tirzepatide 'standard full dose'; 2.4 mg is the semaglutide maintenance dose, and tirzepatide is labeled 2.5-15 mg/week
  • Compounded tirzepatide is not an FDA-approved finished product

The bottom line

Best for: Cost-first shoppers who want transparent, care-inclusive compounded tirzepatide microdosing. Aurelius Health Group is a telehealth platform built around compounded tirzepatide microdosing — a low-dose dual GIP/GLP-1 protocol rather than standard full-dose therapy — with optional NAD+, L-carnitine.

Ranked #321 of 539 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 538 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to Aurelius Health Group.

The 24 programs nearest this one

Pricing, states and verification reflect Aurelius Health Group's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Aurelius Health Group's site. Not medical advice; see our disclosure.

← Back to the value leaderboard